Utah Medical Products Inc (UTMD)
64.57
+0.39
(+0.61%)
USD |
NASDAQ |
Nov 21, 16:00
63.62
-0.95
(-1.47%)
After-Hours: 06:42
Utah Medical Products Enterprise Value: 130.54M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 130.54M |
| November 20, 2024 | 129.22M |
| November 19, 2024 | 130.95M |
| November 18, 2024 | 135.70M |
| November 15, 2024 | 135.56M |
| November 14, 2024 | 137.16M |
| November 13, 2024 | 138.65M |
| November 12, 2024 | 143.36M |
| November 11, 2024 | 143.94M |
| November 08, 2024 | 145.19M |
| November 07, 2024 | 142.85M |
| November 06, 2024 | 142.65M |
| November 05, 2024 | 131.74M |
| November 04, 2024 | 133.94M |
| November 01, 2024 | 132.05M |
| October 31, 2024 | 129.61M |
| October 30, 2024 | 131.81M |
| October 29, 2024 | 132.26M |
| October 28, 2024 | 132.57M |
| October 25, 2024 | 132.15M |
| October 24, 2024 | 132.74M |
| October 23, 2024 | 134.66M |
| October 22, 2024 | 136.11M |
| October 21, 2024 | 137.83M |
| October 18, 2024 | 139.65M |
| Date | Value |
|---|---|
| October 17, 2024 | 137.55M |
| October 16, 2024 | 139.55M |
| October 15, 2024 | 140.51M |
| October 14, 2024 | 140.41M |
| October 11, 2024 | 139.76M |
| October 10, 2024 | 138.07M |
| October 09, 2024 | 137.52M |
| October 08, 2024 | 135.28M |
| October 07, 2024 | 135.52M |
| October 04, 2024 | 135.35M |
| October 03, 2024 | 136.21M |
| October 02, 2024 | 137.28M |
| October 01, 2024 | 138.66M |
| September 30, 2024 | 141.75M |
| September 27, 2024 | 142.84M |
| September 26, 2024 | 143.47M |
| September 25, 2024 | 142.60M |
| September 24, 2024 | 142.81M |
| September 23, 2024 | 141.66M |
| September 20, 2024 | 141.35M |
| September 19, 2024 | 147.22M |
| September 18, 2024 | 144.51M |
| September 17, 2024 | 144.09M |
| September 16, 2024 | 145.03M |
| September 13, 2024 | 147.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
129.22M
Minimum
Nov 20 2024
390.98M
Maximum
Nov 22 2021
246.39M
Average
257.33M
Median
May 03 2023
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| InfuSystems Holdings Inc | 224.07M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.563M |
| Revenue (Quarterly) | 10.00M |
| Total Expenses (Quarterly) | 6.662M |
| EPS Diluted (Quarterly) | 1.02 |
| Gross Profit Margin (Quarterly) | 57.99% |
| Profit Margin (Quarterly) | 35.61% |
| Earnings Yield | 6.61% |
| Operating Earnings Yield | 6.67% |
| Normalized Earnings Yield | 6.875 |